Literature DB >> 29445128

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis.

Katherine A Davies1,2, Maria C Tanzer1,2, Michael D W Griffin3, Yee Foong Mok3, Samuel N Young1, Rui Qin1,4, Emma J Petrie1,2, Peter E Czabotar1,2, John Silke5,6, James M Murphy7,8.   

Abstract

The programmed cell death pathway, necroptosis, relies on the pseudokinase, Mixed Lineage Kinase domain-Like (MLKL), for cellular execution downstream of death receptor or Toll-like receptor ligation. Receptor-interacting protein kinase-3 (RIPK3)-mediated phosphorylation of MLKL's pseudokinase domain leads to MLKL switching from an inert to activated state, where exposure of the N-terminal four-helix bundle (4HB) 'executioner' domain leads to cell death. The precise molecular details of MLKL activation, including the stoichiometry of oligomer assemblies, mechanisms of membrane translocation and permeabilisation, remain a matter of debate. Here, we dissect the function of the two 'brace' helices that connect the 4HB to the pseudokinase domain of MLKL. In addition to establishing that the integrity of the second brace helix is crucial for the assembly of mouse MLKL homotrimers and cell death, we implicate the brace helices as a device to communicate pseudokinase domain phosphorylation event(s) to the N-terminal executioner 4HB domain. Using mouse:human MLKL chimeras, we defined the first brace helix and adjacent loop as key elements of the molecular switch mechanism that relay pseudokinase domain phosphorylation to the activation of the 4HB domain killing activity. In addition, our chimera data revealed the importance of the pseudokinase domain in conferring host specificity on MLKL killing function, where fusion of the mouse pseudokinase domain converted the human 4HB + brace from inactive to a constitutive killer of mouse fibroblasts. These findings illustrate that the brace helices play an active role in MLKL regulation, rather than simply acting as a tether between the 4HB and pseudokinase domains.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29445128      PMCID: PMC6143630          DOI: 10.1038/s41418-018-0061-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  34 in total

1.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

2.  Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.

Authors:  Andreas Linkermann; Jan Hinrich Bräsen; Maurice Darding; Mi Kyung Jin; Ana B Sanz; Jan-Ole Heller; Federica De Zen; Ricardo Weinlich; Alberto Ortiz; Henning Walczak; Joel M Weinberg; Douglas R Green; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

3.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.

Authors:  Jie Zhao; Siriporn Jitkaew; Zhenyu Cai; Swati Choksi; Qiuning Li; Ji Luo; Zheng-Gang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

4.  Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

Authors:  Liming Sun; Huayi Wang; Zhigao Wang; Sudan He; She Chen; Daohong Liao; Lai Wang; Jiacong Yan; Weilong Liu; Xiaoguang Lei; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

6.  [The representation of plant tissues after freeze substitution with special reference to the structural preservation of plastids (author's transl)].

Authors:  D Neumann
Journal:  Acta Histochem       Date:  1973       Impact factor: 2.479

7.  RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.

Authors:  Mark Luedde; Matthias Lutz; Natalie Carter; Justyna Sosna; Christoph Jacoby; Mihael Vucur; Jérémie Gautheron; Christoph Roderburg; Nadine Borg; Florian Reisinger; Hans-Joerg Hippe; Andreas Linkermann; Monika J Wolf; Stefan Rose-John; Renate Lüllmann-Rauch; Dieter Adam; Ulrich Flögel; Mathias Heikenwalder; Tom Luedde; Norbert Frey
Journal:  Cardiovasc Res       Date:  2014-06-11       Impact factor: 10.787

Review 8.  The diverse role of RIP kinases in necroptosis and inflammation.

Authors:  John Silke; James A Rickard; Motti Gerlic
Journal:  Nat Immunol       Date:  2015-07       Impact factor: 25.606

9.  Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis.

Authors:  Jianfeng Wu; Zhe Huang; Junming Ren; Zhirong Zhang; Peng He; Yangxin Li; Jianhui Ma; Wanze Chen; Yingying Zhang; Xiaojuan Zhou; Zhentao Yang; Su-Qin Wu; Lanfen Chen; Jiahuai Han
Journal:  Cell Res       Date:  2013-07-09       Impact factor: 25.617

10.  Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.

Authors:  Tammo Müller; Christin Dewitz; Jessica Schmitz; Anna Sophia Schröder; Jan Hinrich Bräsen; Brent R Stockwell; James M Murphy; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Cell Mol Life Sci       Date:  2017-05-27       Impact factor: 9.261

View more
  23 in total

1.  MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.

Authors:  Cole M Dovey; Jonathan Diep; Bradley P Clarke; Andrew T Hale; Dan E McNamara; Hongyan Guo; Nathaniel W Brown; Jennifer Yinuo Cao; Christy R Grace; Peter J Gough; John Bertin; Scott J Dixon; Dorothea Fiedler; Edward S Mocarski; William J Kaiser; Tudor Moldoveanu; John D York; Jan E Carette
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

2.  Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.

Authors:  Dan E McNamara; Cole M Dovey; Andrew T Hale; Giovanni Quarato; Christy R Grace; Cristina D Guibao; Jonathan Diep; Amanda Nourse; Casey R Cai; Hong Wu; Ravi C Kalathur; Douglas R Green; John D York; Jan E Carette; Tudor Moldoveanu
Journal:  Cell Chem Biol       Date:  2019-04-25       Impact factor: 8.116

3.  Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis.

Authors:  Dan E McNamara; Giovanni Quarato; Cliff S Guy; Douglas R Green; Tudor Moldoveanu
Journal:  J Vis Exp       Date:  2018-08-07       Impact factor: 1.355

4.  Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.

Authors:  Emma J Petrie; Richard W Birkinshaw; Akiko Koide; Eric Denbaum; Joanne M Hildebrand; Sarah E Garnish; Katherine A Davies; Jarrod J Sandow; Andre L Samson; Xavier Gavin; Cheree Fitzgibbon; Samuel N Young; Patrick J Hennessy; Phoebe P C Smith; Andrew I Webb; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

Review 5.  The regulation of necroptosis by post-translational modifications.

Authors:  Yanxiang Meng; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 15.828

6.  Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Authors:  Zikou Liu; Laura F Dagley; Kristy Shield-Artin; Samuel N Young; Aleksandra Bankovacki; Xiangyi Wang; Michelle Tang; Jason Howitt; Che A Stafford; Ueli Nachbur; Cheree Fitzgibbon; Sarah E Garnish; Andrew I Webb; David Komander; James M Murphy; Joanne M Hildebrand; John Silke
Journal:  EMBO J       Date:  2021-10-26       Impact factor: 11.598

7.  A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells.

Authors:  André L Samson; Cheree Fitzgibbon; Komal M Patel; Joanne M Hildebrand; Lachlan W Whitehead; Joel S Rimes; Annette V Jacobsen; Christopher R Horne; Xavier J Gavin; Samuel N Young; Kelly L Rogers; Edwin D Hawkins; James M Murphy
Journal:  Cell Death Differ       Date:  2021-02-15       Impact factor: 12.067

8.  Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance.

Authors:  Laura Ramos Garcia; Tencho Tenev; Richard Newman; Rachel O Haich; Gianmaria Liccardi; Sidonie Wicky John; Alessandro Annibaldi; Lu Yu; Mercedes Pardo; Samuel N Young; Cheree Fitzgibbon; Winnie Fernando; Naomi Guppy; Hyojin Kim; Lung-Yu Liang; Isabelle S Lucet; Andrew Kueh; Ioannis Roxanis; Patrycja Gazinska; Martin Sims; Tomoko Smyth; George Ward; John Bertin; Allison M Beal; Brad Geddes; Jyoti S Choudhary; James M Murphy; K Aurelia Ball; Jason W Upton; Pascal Meier
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

Review 9.  Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators.

Authors:  Jinho Seo; Young Woo Nam; Seongmi Kim; Doo-Byoung Oh; Jaewhan Song
Journal:  Exp Mol Med       Date:  2021-06-01       Impact factor: 8.718

Review 10.  The Killer Pseudokinase Mixed Lineage Kinase Domain-Like Protein (MLKL).

Authors:  James M Murphy
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-08-03       Impact factor: 9.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.